Neuropsychology Associates Llc | |
4123 Okemos Rd Suite 14 Okemos MI 48864-2818 | |
(517) 381-1062 | |
(517) 381-5252 |
Full Name | Neuropsychology Associates Llc |
---|---|
Speciality | Psychologist |
Location | 4123 Okemos Rd, Okemos, Michigan |
Authorized Official Name and Position | Lisa M Bell (PSYCHOLOGIST) |
Authorized Official Contact | 15173811062 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Neuropsychology Associates Llc Po Box 344 Okemos MI 48805-0344 Ph: (517) 381-1062 | Neuropsychology Associates Llc 4123 Okemos Rd Suite 14 Okemos MI 48864-2818 Ph: (517) 381-1062 |
NPI Number | 1932420189 |
---|---|
Provider Enumeration Date | 06/22/2010 |
Last Update Date | 06/22/2010 |
Medicare PECOS PAC ID | 3779614078 |
---|---|
Medicare Enrollment ID | O20100630000720 |
News Archive
A modeling study by Dr. Peter Ellis from the University of Kent indicates that ABO incompatibility between infected patients and susceptible individuals may actually decrease the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 60% or more. His detailed investigation of such "ABO-interference" can be found on the medRxiv preprint server.
A new report from Chile – currently available on the medRxiv* preprint server – reveals how mutations in the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Lambda variant can confer protection from neutralizing antibodies and increase viral infectivity rates, which means massive vaccination campaigns should be accompanied by strict genomic surveillance.
The Alliance of Specialty Medicine (Alliance) today called on Congress to permanently fix Medicare's Sustainable Growth Rate (SGR) after lawmakers once again passed a temporary fix, thereby postponing unprecedented reimbursement cuts to Medicare doctors until 2012.
The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA between 1968 and 1975. It is named after the town of the same name in Massachusetts, where a systematic evaluation of heart health had previously been conducted in the late 1940s.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.
› Verified 8 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1932420189 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 6301008842 (Michigan) | Primary |
Provider Name | Lisa Bell |
---|---|
Provider Type | Practitioner - Clinical Psychologist |
Provider Identifiers | NPI Number: 1821017948 PECOS PAC ID: 1759412059 Enrollment ID: I20100630000752 |
News Archive
A modeling study by Dr. Peter Ellis from the University of Kent indicates that ABO incompatibility between infected patients and susceptible individuals may actually decrease the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 60% or more. His detailed investigation of such "ABO-interference" can be found on the medRxiv preprint server.
A new report from Chile – currently available on the medRxiv* preprint server – reveals how mutations in the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Lambda variant can confer protection from neutralizing antibodies and increase viral infectivity rates, which means massive vaccination campaigns should be accompanied by strict genomic surveillance.
The Alliance of Specialty Medicine (Alliance) today called on Congress to permanently fix Medicare's Sustainable Growth Rate (SGR) after lawmakers once again passed a temporary fix, thereby postponing unprecedented reimbursement cuts to Medicare doctors until 2012.
The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA between 1968 and 1975. It is named after the town of the same name in Massachusetts, where a systematic evaluation of heart health had previously been conducted in the late 1940s.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.
› Verified 8 days ago
News Archive
A modeling study by Dr. Peter Ellis from the University of Kent indicates that ABO incompatibility between infected patients and susceptible individuals may actually decrease the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 60% or more. His detailed investigation of such "ABO-interference" can be found on the medRxiv preprint server.
A new report from Chile – currently available on the medRxiv* preprint server – reveals how mutations in the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Lambda variant can confer protection from neutralizing antibodies and increase viral infectivity rates, which means massive vaccination campaigns should be accompanied by strict genomic surveillance.
The Alliance of Specialty Medicine (Alliance) today called on Congress to permanently fix Medicare's Sustainable Growth Rate (SGR) after lawmakers once again passed a temporary fix, thereby postponing unprecedented reimbursement cuts to Medicare doctors until 2012.
The so-called Framingham cardiovascular risk calculator was developed in 1991 on the basis of data gathered in the USA between 1968 and 1975. It is named after the town of the same name in Massachusetts, where a systematic evaluation of heart health had previously been conducted in the late 1940s.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.
› Verified 8 days ago
Shawn Johnson, Ph.d., Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4111 Okemos Rd Ste 104, Okemos, MI 48864 Phone: 517-347-4755 | |
Gilbert Counseling Services Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4084 Okemos Rd, Okemos, MI 48864 Phone: 517-347-4848 | |
Msu Health Care Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1600 W Grand River Ave Ste 2, Okemos, MI 48864 Phone: 517-349-5796 Fax: 517-349-5796 | |
Dr Lori Naughton Psy D Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1745 Hamilton Rd, #325, Okemos, MI 48864 Phone: 517-676-9788 Fax: 517-676-3438 | |
Push Therapy Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2111 University Park Dr Ste 400, Okemos, MI 48864 Phone: 517-258-0228 | |
Envision Therapy Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1745 Hamilton Rd Ste 355, Okemos, MI 48864 Phone: 517-721-1244 | |
Integrity Counseling Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4747 Okemos Rd, Okemos, MI 48864 Phone: 517-347-0988 Fax: 517-349-3755 |